Activella Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Long-Term Safety and Efficacy of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Conditions:   Heavy Menstrual Bleeding;   Uterine Fibroids Interventions:   Drug: Elagolix;   Drug: E2/NETA;   Other: Elagolix Placebo;   Other: E2/NETA Placebo Sponsor:   AbbVie Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2017 Category: Research Source Type: clinical trials